These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

535 related articles for article (PubMed ID: 16799100)

  • 1. Erythropoietin and blood doping.
    Robinson N; Giraud S; Saudan C; Baume N; Avois L; Mangin P; Saugy M
    Br J Sports Med; 2006 Jul; 40 Suppl 1(Suppl 1):i30-4. PubMed ID: 16799100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medicine and science in the fight against doping in sport.
    Catlin DH; Fitch KD; Ljungqvist A
    J Intern Med; 2008 Aug; 264(2):99-114. PubMed ID: 18702750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A third generation approach to detect erythropoietin abuse in athletes.
    Sharpe K; Ashenden MJ; Schumacher YO
    Haematologica; 2006 Mar; 91(3):356-63. PubMed ID: 16503554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Doctors belonging to the Senegalese Association of Sport Medicine and doping in sports: survey on knowledge and attitudes].
    Dièye AM; Diallo B; Fall A; Ndiaye M; Cissè F; Faye B
    Sante; 2005; 15(3):167-70. PubMed ID: 16207578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second-generation blood tests to detect erythropoietin abuse by athletes.
    Gore CJ; Parisotto R; Ashenden MJ; Stray-Gundersen J; Sharpe K; Hopkins W; Emslie KR; Howe C; Trout GJ; Kazlauskas R; Hahn AG
    Haematologica; 2003 Mar; 88(3):333-44. PubMed ID: 12651273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Procedures for monitoring recombinant erythropoietin and analogues in doping control.
    Segura J; Pascual JA; Gutiérrez-Gallego R
    Anal Bioanal Chem; 2007 Aug; 388(7):1521-9. PubMed ID: 17516052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OMICS-strategies and methods in the fight against doping.
    Reichel C
    Forensic Sci Int; 2011 Dec; 213(1-3):20-34. PubMed ID: 21862249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rogue athletes and recombinant DNA technology: challenges for doping control.
    Azzazy HM; Mansour MM
    Analyst; 2007 Oct; 132(10):951-7. PubMed ID: 17893796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of EPO doping and blood doping: the haematological module of the Athlete Biological Passport.
    Schumacher YO; Saugy M; Pottgiesser T; Robinson N
    Drug Test Anal; 2012 Nov; 4(11):846-53. PubMed ID: 22374784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second generation blood tests to detect erythropoietin abuse by athletes: effective but not preventive?
    Lippi G; Franchini M; Guidi G
    Haematologica; 2004 Apr; 89(4):ELT05. PubMed ID: 15075118
    [No Abstract]   [Full Text] [Related]  

  • 11. A global strategy for prevention and detection of blood doping with erythropoietin and related drugs.
    Cazzola M
    Haematologica; 2000 Jun; 85(6):561-3. PubMed ID: 10870110
    [No Abstract]   [Full Text] [Related]  

  • 12. Doping in the recombinant era: strategies and counterstrategies.
    Azzazy HM; Mansour MM; Christenson RH
    Clin Biochem; 2005 Nov; 38(11):959-65. PubMed ID: 16286094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Practical experience with the implementation of an athlete's biological profile in athletics, cycling, football and swimming.
    Zorzoli M; Pipe A; Garnier PY; Vouillamoz M; Dvorak J
    Br J Sports Med; 2014 May; 48(10):862-6. PubMed ID: 24648438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood test may help discourage doping.
    Expert Rev Mol Diagn; 2002 Mar; 2(2):95. PubMed ID: 11962345
    [No Abstract]   [Full Text] [Related]  

  • 15. Blood doping: risks to athletes' health and strategies for detection.
    Oliveira CD; Bairros AV; Yonamine M
    Subst Use Misuse; 2014 Jul; 49(9):1168-81. PubMed ID: 24766400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharma-clinics. Doping with erythropoietin or the misuse of therapeutic advances].
    Scheen AJ
    Rev Med Liege; 1998 Aug; 53(8):499-502. PubMed ID: 9810213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detecting doping use: more than an analytical problem.
    Delanghe JR; Maenhout TM; Speeckaert MM; De Buyzere ML
    Acta Clin Belg; 2014; 69(1):25-9. PubMed ID: 24635395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarker monitoring in sports doping control.
    Pottgiesser T; Schumacher YO
    Bioanalysis; 2012 Jun; 4(10):1245-53. PubMed ID: 22651568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Medication, athletes and doping regulations].
    Hartgens F
    Ned Tijdschr Geneeskd; 2008 Aug; 152(33):1844-8. PubMed ID: 18783164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of human reticulocyte genes reveals altered erythropoiesis: potential use to detect recombinant human erythropoietin doping.
    Varlet-Marie E; Audran M; Lejeune M; Bonafoux B; Sicart MT; Marti J; Piquemal D; Commes T
    Haematologica; 2004 Aug; 89(8):991-7. PubMed ID: 15339684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.